Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A3 | P48764 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.32 |
| ▸ | GLP1R | P43220 | 8/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24916689 | 1.00 | SLC9A3 (0.36) | SLC9A3GAAL3MBTL1LPAR1LPAR2 | |
| SCHEMBL25985594 | 0.95 | SLC9A3 (0.38) | SLC9A3GAAL3MBTL1LPAR1LPAR2 | |
| SCHEMBL24916770 | 0.89 | L3MBTL1 (0.40) | SLC9A3GAAL3MBTL1 | |
| SCHEMBL25978459 | 0.86 | TLR2 (0.35) | SLC9A3GAALPAR1LPAR2MEN1 | |
| SCHEMBL25978452 | 0.86 | TLR2 (0.35) | SLC9A3GAALPAR1LPAR2MEN1 | |
| SCHEMBL24916783 | 0.85 | — | — | |
| SCHEMBL25344833 | 0.83 | L3MBTL1 (0.41) | SLC9A3GAAL3MBTL1 | |
| SCHEMBL24917491 | 0.83 | CA12 (0.32) | L3MBTL1MEN1KMT2A | |
| SCHEMBL25346796 | 0.82 | SLC9A3 (0.33) | SLC9A3GAALPAR1LPAR2 | |
| SCHEMBL25524359 | 0.82 | SLC9A3 (0.33) | SLC9A3GAALPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023288033-A1 | ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES | LYCIA THERAPEUTICS, INC. (US) | 2023-01-19 | — | — | WO | disclosed |